Table 3 Represented detailed treatment in patients with ADHD and patients without ADHD
From: Evaluation of the frequency of attention deficit hyperactivity disorder in patients with asthma
Treatment | With ADHD (n = 46) | Without ADHD (n = 631) | p value |
|---|---|---|---|
Using salbutamol spray | Â | Â | Â |
 Always | 34 (73.9%) | 475 (75.3%) | 0.830 |
 During exercise | 1 (2.2%) | 12 (1.9%) |  |
 In a cold weather | 9 (19.6%) | 103 (16.3%) |  |
 During dyspnea | 2 (4.3%) | 41 (6.5%) |  |
Type of spray | Â | Â | Â |
 Fluticasone | 19 (41.3%) | 285 (45.3%) | 0.421 |
 Combinationa | 14 (30.4%) | 222 (35.2%) |  |
 Salbutamol | 12 (26.1%) | 104 (16.5%) |  |
 Other | 1 (2.2%) | 19 (3%) |  |
Type of drug | Â | Â | Â |
 None | 13 (28.3%) | 183 (29%) | 0.646 |
 Anti-leukotriene | 21 (45.7%) | 313 (49.6%) |  |
 Antihistamine | 6 (13%) | 85 (13.5%) |  |
 Corticosteroid | 6 (13%) | 50 (7.9%) |  |